Indian drug maker Intas Pharmaceuticals, which is backed by the Abu Dhabi Investment Authority (ADIA) and homegrown private equity giant ChrysCapital, is in advanced talks to acquire a stake in Globion, a manufacturer of poultry vaccines and veterinary medicines, DealStreetAsia has learnt.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
